The CEO and President of R&D selling on the same day is a modest caution flag against the overwhelmingly bullish analyst consensus. Monitor for any upcoming clinical data readouts or pipeline updates that could explain the timing. The dollar amount is too small to be a strong bearish signal, but the cluster nature and seniority of sellers warrant watching the next 8-K or press release for context.
Price Chart
Executive Summary
Two top executives at Relay Therapeutics — CEO Sanjiv Patel and President of R&D Donald Bergstrom — sold a combined $1.07M in open-market sales on September 8, 2026. While the dollar amount is modest relative to the $4.2B market cap (~0.03%), the cluster involves the CEO and President of R&D selling on the same day, which warrants attention. The stock has a 95% analyst buy rating and strong institutional support, but the insider sales introduce a note of caution against the bullish consensus.
Key Financial Metrics
Key Facts
- CEO Sanjiv Patel sold 48,199 shares at $18.94 for $912,889 on September 8, 2026.
- President of R&D Donald Bergstrom sold 8,530 shares at $18.97 for $161,814 on September 8, 2026.
- CFO Thomas Catinazzo also sold 17,717 shares at $18.94 for $335,560 on September 8, 2026.
- Total cluster value is $1.07M, representing approximately 0.03% of the $4.2B market cap.
- The stock has 95% analyst buy rating (19 Buy/Strong Buy, 1 Hold, 0 Sell).
- Institutional 13F shows strong accumulation: 11 adds, 6 doubled positions, only 2 trims.
Financial Impact
Insider sales of $1.07M represent 0.03% of market cap — trivial in absolute size but notable for involving the CEO and President of R&D on the same day.
Risk Factors
- Insider sales by CEO and President of R&D could signal reduced conviction ahead of upcoming pipeline milestones.
- The stock's high valuation (95% analyst buy rating) leaves limited upside if clinical data disappoints.
- Historical performance shows the model's prior bearish calls on RLAY had strong negative T+20 returns, suggesting the stock can drop sharply on negative news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RLAY-1789030928152 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | Insider Cluster | $18.66 $18.84 | ▲ +0.96% | ▲ +1.62% | $18.96 (+1.61%) |
Aug 28, 2026 5w ago | Insider Cluster | $18.77 $19.04 | ▼ −1.44% | ▼ −1.33% | $18.96 (−1.01%) |
Aug 18, 2026 6w ago | Insider Cluster | $20.61 $20.57 | ▲ +0.19% | ▼ −0.01% | $18.96 (+8.01%) |
Jul 8, 2026 12w ago | Insider Cluster | $19.63 $19.08 | ▼ −2.80% | ▼ −3.66% | $18.96 (−3.41%) |
Jun 22, 2026 14w ago | 144 | $17.44 $19.74 | ▲ +13.19% | ▲ +12.18% | $18.96 (+8.72%) |
Jun 12, 2026 16w ago | Institutional Cluster | $14.81 $15.88 | ▲ +7.22% | ▲ +6.55% | $18.96 (+28.02%) |
May 21, 2026 19w ago | 8-K | $13.53 $14.26 | ▼ −5.40% | ▼ −3.74% | $18.96 (−40.13%) |
May 21, 2026 19w ago | Press Release | $13.66 $14.05 | ▼ −2.86% | ▼ −1.01% | $18.96 (−38.80%) |
May 19, 2026 19w ago | 424B5 | $13.02 $13.90 | ▼ −6.76% | ▼ −4.96% | $18.96 (−45.62%) |
May 19, 2026 19w ago | Press Release | $13.02 $14.43 | ▼ −10.83% | ▼ −9.59% | $18.96 (−45.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access